Alexion Pharmaceuticals, Inc.
Operating companyCorporate group: AstraZeneca Group · HQ: United Kingdom
Not counted above: 3 file-access requests (R. 262.1(b) RoP), where someone asked to read a case file. View
Alexion Pharmaceuticals, Inc. has been party to 13 Unified Patent Court cases, 4 times as claimant and 9 times as respondent. The most recent on record is UPC CoA 152/2026 at the Court of Appeal, brought by Carpmaels & Ransford LLP.
- 2026-09-15UPC CoA 152/2026Court of AppealFile-access requestCarpmaels & Ransford LLP v Samsung Bioepis NL B.V.
- 2026-09-15UPC CoA 153/2026Court of AppealFile-access requestCarpmaels & Ransford LLP v Amgen Zdravila D.O.O.
- 2025-08-14UPC CoA 750/2025Court of AppealWithdrawnSamsung Bioepis NL B.V. v Alexion Pharmaceuticals, Inc.
- 2025-08-13UPC CoA 744/2025Court of AppealWithdrawnSamsung Bioepis NL B.V. v Alexion Pharmaceuticals, Inc.
- 2025-07-22UPC CFI 674/2025Hamburg LD—Samsung Bioepis NL B.V. v Alexion Pharmaceuticals, Inc.
- 2025-01-23UPC CFI 51/2025Hamburg LD—Samsung Bioepis NL B.V. v Alexion Pharmaceuticals, Inc.
- 2025-01-22UPC CFI 40/2025Hamburg LDCosts onlySamsung Bioepis NL B.V. v Alexion Pharmaceuticals, Inc.
- 2025-01-21UPC APP 3053/2025Hamburg LD—Amgen GmbH v Alexion Pharmaceuticals, Inc.
- 2024-11-08UPC APP 60271/2024Hamburg LDFile-access requestName not displayed for GDPR reasons. Represented by Jochen HÖHFELD v Alexion Pharmaceuticals, Inc.
- 2024-10-31UPC CFI 642/2024Milan CDWithdrawnAMGEN Switzerland AG Vilniaus filialas v Alexion Pharmaceuticals, Inc.